Nermine Mogahed Fawzy Hussein Mogahed Selected Research

Spiramycin

3/2022	Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation.
1/2022	The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nermine Mogahed Fawzy Hussein Mogahed Research Topics

Disease

3	Toxoplasmosis 03/2022 - 09/2021
2	Infections 05/2022 - 09/2021
2	Schistosomiasis mansoni 05/2022 - 06/2021
2	Schistosomiasis (Bilharziasis) 05/2022 - 06/2021
1	Parasitic Diseases (Parasitic Disease) 09/2021
1	Persistent Infection 09/2021
1	Cerebral Toxoplasmosis 09/2021
1	Cysts 09/2021

Drug/Important Bio-Agent (IBA)

2	Celecoxib (Celebrex)FDA Link 05/2022 - 06/2021
2	Praziquantel (Biltricide)FDA Link 05/2022 - 06/2021
2	ChitosanIBA 03/2022 - 01/2022
2	SpiramycinIBA 03/2022 - 01/2022
1	Lipid NanoparticlesIBA 05/2022
1	Propolis (Bee Bread)IBA 01/2022
1	AlginatesIBA 01/2022
1	Pharmaceutical PreparationsIBA 09/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2021
1	Auranofin (Ridaura)FDA Link 09/2021

Therapy/Procedure

1	Mass Drug Administration 06/2021
1	Oral Administration 06/2021